Leflunomide monotherapy in patients with early rheumatoid arthritis: Results of the Russian national Arava mono study
The treatment of early rheumatoid arthritis (RA) is usually started using one of the synthetic disease-modifying antirheumatic drugs. The choice of these drugs is very limited and leflunomide (LEF) is one of the most promising agents. The present study assessed the results of using the standard LEF...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2012-06-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/840 |